admin

SHOCKING MMR vaccine trial results released via FOIA

 Uncategorized  Comments Off on SHOCKING MMR vaccine trial results released via FOIA
Apr 142019
 

A Freedom of Information Act (FOIA) request results in the release of trial results of MMR vaccines that show a shocking percentage of children participating in the study suffering from gastrointestinal illness and upper-respiratory illness after receiving the Measles, Mumps & Rubella shot.

For the full HIGHWIRE episode with Del Bigtree click HERE

 Posted by at 9:18 am

The Vaccine Debate

 Uncategorized  Comments Off on The Vaccine Debate
Jan 062019
 

By Full Measure Staff

Full Measure is a weekly Sunday news program focusing on investigative, original and accountability reporting. The host is Sharyl Attkisson, five-time Emmy Award winner and recipient of the Edward R. Murrow award for investigative reporting. She is backed by a team of award winning journalists.

Each week, we have a cover story that explores untouchable topics in a fearless way including: immigration, terrorism, government waste, national security and whistleblower reports on government and corporate abuse and misdeeds.

Full Measure is broadcast to 43 million households in 79 markets on 162 Sinclair Broadcast Group stations, including ABC, CBS, NBC, FOX, CW, MyTV, Univision and Telemundo affiliates. It also streams live Sunday mornings at 9:30 a.m. ET.

http://fullmeasure.news/

 Posted by at 11:42 am

New Report: 1 in 40 Kids Has Autism

 Uncategorized  Comments Off on New Report: 1 in 40 Kids Has Autism
Nov 282018
 

 Posted by at 12:07 pm

New Study Reveals Vaccine Makers Fail to Test Safety of Aluminum Adjuvants Against Placebo

 Uncategorized  Comments Off on New Study Reveals Vaccine Makers Fail to Test Safety of Aluminum Adjuvants Against Placebo
Nov 242018
 

Posted by Celeste McGovern on Nov 19, 2018 1:32:03 PM
CHILDREN’S MEDICAL SAFETY RESEARCH INSTITUTE

Aluminum salts, a key ingredient added in growing amounts to numerous childhood and adult vaccines, have never been tested for their effects on health in humans, a new review paper from British researchers says.

“Aluminum based adjuvants are effective and cheap but are they safe?” the team of researchers at Keele University ask in the study published this month in Allergy, Asthma & Clinical Immunology.

Although aluminum has been used for decades as an adjuvant to provoke the immune system to make antibodies to other vaccine ingredients, it works precisely because it is toxic, said Christopher Exley, who has studied the metal’s adverse effects biological systems from fish to humans for more than three decades. His paper with Emma Shardlow and Matthew Mold reviews what is known about the different modes of action of different aluminum salts and confirms that it may account for the wide spectrum of serious adverse events associated with vaccines.

“Aluminium-adjuvanted vaccines have a long history of clinical successes and a commensurately long history of vaccine-related adverse events,” the scientists write. “Since there is no requirement to demonstrate the safety of [aluminum-based adjuvants] ABAs, one could quickly surmise that adverse events following vaccination are the direct or indirect effects of ABAs.”

“What might be the cause of such events, ranging from health issues directly associated with the injection site to brain encephalopathy and death?” Exley asks in a related blog published today in the Hippocratic Post.

“We know that aluminium adjuvants are toxic at the injection site, this toxicity is essentially their mode of action (see https://www.hippocraticpost.com/infection-disease/aluminium-adjuvants-vaccines/), and evidence is burgeoning that this toxicity is also being manifested away from the injection site (see https://www.hippocraticpost.com/infection-disease/aluminium-and-autism/).”

No placebos

Taking aim at pharmaceutical giant Merck, the manufacturer of Gardasil and Gardasil 9 vaccines against the human papilloma virus (HPV), Exley notes that the company has “prevented any independent study of its proprietary adjuvant and concomitantly this vaccine has arguably the highest frequency of recorded adverse events of all vaccines and this according to the manufacturer’s own data!”

 

Continue Reading…

 Posted by at 2:32 pm

The Varicella Vaccine, Skyrocketing Shingles and CDC Chicanery

 Uncategorized  Comments Off on The Varicella Vaccine, Skyrocketing Shingles and CDC Chicanery
May 092018
 
By the World Mercury Project Team

“Collusion” is the word du jour, and the practice’s very characteristics—deception, fraud, misrepresentation and secrecy—often prevent collusive acts from coming to light. In the scientific research community, would-be deceivers draw on a variety of tricks to slant their message, including manipulating data, employing other questionable research practices, not disclosing conflicts of interest, harassing whistleblowers and engaging in outright censorship.

The Centers for Disease Control and Prevention (CDC) is no stranger to any of these tactics, but eventually, as Shakespeare once predicted, the “truth will out.” Critics and senior scientists, in growing numbers, have been pulling back the veil on the CDC’s unethical modus operandi, arguing that questionable practices have become “the norm and not the rare exception.” Adding to this emerging picture of a public agency captive to “rogue interests,” a March 2018 article in the Annals of Clinical Pathology describes CDC’s suppression of inconvenient research findings pertaining to its Universal Varicella Vaccination Program. The author, an independent computer scientist, outlines in morbidly fascinating detail the “collusion” between CDC and its local public health partner to conceal unwanted chickenpox vaccine outcomes from the public.

One virus, two diseases

Prior to the 1990s, natural chickenpox (caused by the varicella zoster virus) was a nearly universal childhood experience and, in children with normal immune systems, played out as a mild disease that conferred long-term immunity. In 1995, without any compelling medical reason to do so, the CDC added the chickenpox vaccine to the childhood vaccine schedule for 12- to 15-month-olds. In 2006, acknowledging the problem of waning vaccine effectiveness, it indicated that four- to six-year-old children needed to get a second (booster) shot.

Read More…

 Posted by at 8:25 pm